Innovation as a Critical Success Factor: an Exploratory Study about the Partnership among University with Pharmaceutical Industry in Brazil
AbstractInteraction between universities and companies is common in Countries considered to be developed and innovative. In Brazil, this strategy is not widely used, although some relevant actions have produced good results in the pharmaceutical sector. The Brazilian Innovation Law, which is considered a milestone, created the Technology Innovation Centers (TICs) in universities, and is seen by the Ministry of Health in Brazil as having great strategic promise within the area of drugs and medicine. In this regard, this article seeks to present the findings of an exploratory research project investigating the participation of Brazilian universities in the formation of strategic partnerships focused on the development of drugs, after the advent of the Brazilian Innovation Law. An exploratory study was used as an instrument of methodological support, backed by a survey whose results allowed the authors to identify some significant reflections structured in the university-pharmaceutical industry-government approach.
ACHÉ. (2011). Acheflan® Aerosol: da natureza vem o mais novo tratamento para traumas esportivos. http://www.ache.com.br/PressRoom/News.aspx?NewsId=156 [Accessed June 11, 2011]
BEKKERS, R. e Bodas Freitas, I. M. (2008) Analyzing knowledge transfer channels between universities and industry: To what degree do sectors also matter? Research Policy, v.37, n.10, p.1837-1853.
BIGLIARDI, B., COLACINO, P., et al. (2011) Innovative characteristics of small and medium enterprises. Journal of Technology Management & Innovation, v.6, issue 2, p.83-93. 2011.
BRAZIL. (2001). Provisionary Measure no. 2.190-34 of 23 August 2001. Changes the provisions of Laws no. 9.782, of 26 January 1999, which defines the National System of Sanitary Surveillance and creates the National Agency of Sanitary Surveillance, and no. 6.437 of 20 August 1977, which configures violations of federal sanitary legislation and establishes the respective sanctions, and provides additional provisions. Official Gazette, Presidency of the Republic, Staff, Chief Deputy of Legal Affairs, Brasilia. Section 1
COMPETITION, E. C. (2010). Pharmaceuticals and public health in the EU: Proposals to the high level committee on health for policies and actions in the framework of the treaty of Amsterdam. 28 March 2000. http://ec.europa.eu/competition/consultations/2009_pharma/index.html [Accessed September 12, 2010]
CONDE, M.V. F. e Araújo-Jorge,T. C. (2003). Modelos e concepções de inovação: a transição de paradigmas, a reforma da C&T brasileira e as concepções de gestores de uma instituição pública de pesquisa em saúde. Cien Saude Colet, v.8, n.3, p.727-741.
CUATRECASAS, P. (2006). Drug discovery in jeopardy. Journal of Clinical Investigation, v.116, n.11, p.2837-2842.
DEMAIN, A. L. (2001). The relationship between universities and industry: the American university perspective. Food Technology and Biotechnology, v.39, n.3, p.157-160.
DZISAH, J. e Etzkowitz, H. (2008).Triple helix circulation: the heart of innovation and development. International Journal of Technology Management and Sustainable Development, v.7, n.2, p.101-115.
ELMUTI, D.,Abebe, M., et al. (2005). An overview of strategic alliances between universities and corporations. Journal of Workplace Learning, v.17, n.1/2, p.115-129.
GOLDBERG, S. SUS economiza com fabricação de 22 produtos no país. http://www.sincofarma.org.br/noticias/noticiasdescricao.asp?Textos_ID=14058 [Accessed November
GREWAL, R., Chakravarty, A., et al. (2008). Counting chickens before the eggs hatch: Associating new product development portfolios with shareholder expectations in the pharmaceutical sector. International Journal of Research in Marketing, v.25, n.4, p.261-272.
IBGE. (2010) Pesquisa de Inovação Tecnológica 2008. 2010. http://www.pintec.ibge.gov.br/index.php?option=com_content&view=article&id=56:ibge-divulga-os-resultados-da-pintec-2008&catid=7:noticias&Itemid=10 [Accessed January, 2011]
KUNZ, I. (2003). Relação Universidade-Empresa: uma análise a partir da interação Unicamp-empresas no período 1996-2001. (Masters). Dissertation, UNICAMP, são Paulo.
LEE, Y. S. (2000). The sustainability of university-industry research collaboration: an empirical assessment.The Journal of Technology Transfer, v.25, n.2, p.111-133.
MARTIN, B. R. e Etzkowitz, H. (2000). The origin and evolution of the university species. Paper presented at the Organisation of Mode.
MATTAR, F. N. (1996). Pesquisa de marketing.Atlas Publisher, São Paulo, SP
OHBA, M. Collaborating to compete: a search into capabilities and strategic alliances in the pharmaceutical industry. Journal of Technology Management & Innovation, v.2, issue 2, p.18-30. 2007.
PEREIRA, V. (2009). Cooperação universidade empresa: estudo dos impactos da lei de inovação sobre a parceria Petrobrás-UFRJ. Niterói. 2009. 37 f. Final Project. (Expert level). Post Graduate in Planning, Construction and Assembly Work at the Fluminense Federal University, Niterói.
QUERIDO, A.L.S., LAGE, C.L.S., VASCONCELLOS, A.G. What is the destiny of patents of Brazilian Universities? Journal of Technology Management & Innovation, v.6, issue 1, p.46-57. 2011.
RADAELLI, V. (2006). A Inovação na Indústria Farmacêutica: forças centrípetas e forças centrífugas no processo de internacionalização. Campinas, 2006. 176 f. Dissertation (Masters in Political Science and Technology). Institute of Geosciences, State University of Campinas, Campinas, SP.
ROCHA, M. de M. (2011). Avaliação da parceria entre indústria farmacêutica e universidade como estratégia competitiva para a inovação de medicamentos no Brasil. Niterói, 182 f. Dissertations (Masters in Production Engineering). Fluminense Federal University, Niterói, RJ.
SALOMON, M. F. B. (2008).A política de patentes na relação empresa-universidade: o caso Cristália. Itajubá. 77 f. Disser- tation (Masters in Production Engineering). Production Engineering, Federal University of Itajubá, Itajubá
SANTORO, M. D. (2000). Success breeds success: The linkage between relationship intensity and tangible outcomes in industry-university collaborative ventures. The Journal of High Technology Management Research, v.11, n.2, p.255-273.
SAÚDE, M. D. (2008). Política Nacional de Ciência, Tecnologia e Inovação em Saúde. Brasília- DF: Secretaria de Ciência Tecnologia e Insumos Estratégicos Departamento de Ciência e Tecnologia. Ministério da Saúde. 2a edição.
SBRAGIA, R., Andreassi, T., et al. (2006). Inovação: como vencer esse desafio empresarial. Clio Publisher, São Paulo.
SEGATTO, A. P. (1996). Análise do processo de cooperação tecnológica universidade-empresa: um estudo exploratório. Dissertation (Masters in Administration). College of Economics, Administration and Accounting, University of São Paulo. SP.
STAL, E. e Fujino, A. (2006). As relações universidade-empresa no Brasil sob a ótica da Lei de Inovação. Revista de Administração e Inovação, v.2, n.1, p.5-19.
SCHUMPETER, J. A. (1947). The creative response in economic history. The Journal of Economic History, v.7, n.2, p.149-159.
SCHWAB, K. e Salai-I-Martin, X. (2010). The Global Competitiveness Report 2010–2011:World Economic Forum.
SENNES, R., Mendes, R. C., et al. (2009) Propriedade Intelectual e Inovação: Uma Análise das Principais Empresas e Universidades Brasileiras. Prospectiva Consultoria.
SILVA, C.L., OLIVEIRA, A. J. Brazilian industry policy after 1990: focusing on the pharmaceutical industry. Journal of Technology Management & Innovation, v.2, issue 3, p. 71-84. 2007.
VIEIRA,V. M. M. e Ohayon, P. (2008). Inovação em fármacos e medicamentos: estado-da-arte no Brasil e políticas de P&D. Revista Economia & Gestão, v.6, n.13.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).